Hutchison China Meditech Ltd (HCM)

 

Latest News

Broker Forecast - Panmure Gordon issues a broker note on Hutchison China Meditech Ltd

Panmure Gordon today reaffirms its buy investment rating on Hutchison China Meditech Ltd (LON:HCM) and raised its...

Chi-Med Presents Clinical Data at ASCO 2017

RNS Number: 5131F Hutchison China Meditech Limited 18 May 2017 Press Release Chi-Med Presents Clinical Data at ASCO 2017 Annual Meeting - FRESCO Phase III trial results for fruquintinib in colorectal cancer in an oralpresentation- - Five abstracts in total accepted for fruquintinib, savolitinib andsulfatinib- London: Thursday, May 18, 2017: Hutchison China Med...

Total Voting Rights

RNS Number: 7219D Hutchison China Meditech Limited 28 April 2017 Total Voting Rights London: Friday , April 28, 2017: For information purposes, Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) hereby notifies the market that as at April 28, 2017, the issued share capital of Chi-Med consisted of 60,735,104 ordinary shares of US$1.00 each, with...

Results of Annual General Meeting

RNS Number: 5842D Hutchison China Meditech Limited 27 April 2017 Results of Annual General Meeting London: Thursday, April 27, 2017: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announces that all ordinary resolutions and special resolutions put to its Annual General Meeting ("AGM") held on April 27, 2017 were duly passed. T...

All News

DateHeadlineSource
18-05-17Broker Forecast - Panmure Gordon issues a broker note on Hutchison China Meditech LtdStockMarketWire
18-05-17Chi-Med Presents Clinical Data at ASCO 2017RNS
28-04-17Total Voting RightsRNS
27-04-17Results of Annual General MeetingRNS
13-04-17Why Shell was kicked out of this top-performing portfolioInteractive Investor
07-04-17Chi-Med present pre-clinical data at AACRStockMarketWire
07-04-17Pre-clinical Data Presented at AACRRNS
31-03-17Total Voting RightsRNS
29-03-17Director Deals - Hutchison China Meditech Ltd (HCM)StockMarketWire
29-03-17Vesting of LTIP awardsRNS
28-03-17Grant of Share Options under Share Option SchemeRNS
27-03-172016 Annual Report and Notice of AGMRNS
24-03-17Chi-Med chief scientific officer joins board StockMarketWire
24-03-17Appointment of DirectorRNS
21-03-17Chi-Med to host R&D BriefingsRNS
20-03-17Director Deals - Hutchison China Meditech Ltd (HCM)StockMarketWire
20-03-17Directors' Share DealingRNS
16-03-17Grant of Awards under Long Term Incentive PlanRNS
13-03-17Hutchison China MediTech shares tipped to hit record highInteractive Investor
13-03-17Higher commodity prices boost FTSE as May considers triggering Article 50StockMarketWire
13-03-17Record revenues and net income at Chi-Med StockMarketWire
13-03-17Publication of Form 20-FRNS
13-03-17Final ResultsRNS
10-03-17Chi-Med presents pre-clinical data at ENETSStockMarketWire
10-03-17Sulfatinib Phase Ib/II Results Presented at ENETSRNS
10-03-17Sulfatinib Phase Ib/II Results Presented at ENETSRNS
03-03-17Chi-Med reveals positive results from cancer drug trial StockMarketWire
03-03-17Positive Fruquintinib Pivotal Phase III ResultsRNS
28-02-17Board changes at HCMStockMarketWire
28-02-17Change of DirectorsRNS
20-02-17Chi-Med starts Savolitinib PSC trial in ChinaStockMarketWire
20-02-17Start of Phase II Savolitinib PSC trial in ChinaRNS
20-02-17Start of Phase II Savolitinib PSC trial in ChinaRNS
14-02-17Chi-Med and AZ to present savolitinib results at symposiumStockMarketWire
14-02-17Initiates Phase I of Novel FGFR Inhibitor HMPL-453RNS
14-02-17Savolitinib PRCC Results Presentation at ASCO GURNS
06-02-17Chi-Med to Announce 2016 Final ResultsRNS
01-02-17Change of DirectorsRNS
20-01-17Why resurgent AIM could keep rising Interactive Investor
16-01-17Change of DirectorsRNS

RSS feeds

  • Editorial news feed for LSE:HCM Editorial
  • Regulatory news feed for LSE:HCM Regulatory